FOREVER*ECHINACEA* SUPREME COMBINATION PRODUCT TABLET

Indications

• Respiratory conditions
• Cough
• Bronchitis
• Digestive disorders
• Skin conditions
• Wound healing
• Inflammation

Dosage

Children: As with adults, paediatric dosing should be determined based on traditional practices and clinical judgement, due to the absence of established dosages.

Adults: Dosage should be guided by traditional usage and clinical evidence, as specific dosing information is not standardized.

Mechanism of action

The bioactive compounds in angustifolia exhibit their effects primarily through modulation of inflammatory pathways and oxidative stress. Flavonoids present in the plant have been shown to inhibit pro-inflammatory cytokines and enzymes, leading to reduced inflammation. Additionally, the antimicrobial properties are attributed to the ability of these compounds to disrupt bacterial cell membranes and inhibit their growth.

Pharmacodynamics

The pharmacodynamic properties of angustifolia are closely related to its active constituents, which exert antioxidant and anti-inflammatory effects. These actions can help alleviate symptoms associated with respiratory conditions such as cough and bronchitis, as well as promote healing in skin injuries. The plant's antimicrobial activity also aids in preventing infections, further supporting its use in traditional medicine.

Pharmacokinetics

The pharmacokinetics of angustifolia have not been extensively studied. However, it is known that the active compounds are likely absorbed through the gastrointestinal tract when ingested, with potential metabolism occurring in the liver. The elimination half-life and specific metabolic pathways remain largely undefined due to the lack of comprehensive clinical studies.

Pregnancy

The safety of angustifolia during pregnancy has not been established. Caution is advised.

Breast-feeding

Limited information is available on the excretion of angustifolia in breast milk. Caution is recommended.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Prevention of the common cold
• Treatment of upper respiratory tract infections
• Support for immune system function

Dosage

Children: Refer to specific product guidelines as doses can vary depending on the formulation and concentration of echinacea.

Adults: Refer to specific product guidelines as doses can vary depending on the formulation and concentration of echinacea.

Mechanism of action

Echinacea is thought to stimulate the immune system by increasing the activity of macrophages and other immune cells. It may enhance the production of cytokines, which are critical for coordinating the immune response. The active components, including alkylamides, glycoproteins, and polysaccharides, may also exhibit anti-inflammatory effects.

Pharmacodynamics

Echinacea shows immunomodulatory effects, enhancing phagocytosis, promoting the release of interferons, and increasing the number of white blood cells. It may also exhibit antioxidant properties, reducing oxidative stress in immune cells. These effects contribute to its potential in reducing the duration and severity of cold symptoms.

Pharmacokinetics

The pharmacokinetics of echinacea are not well-defined due to its complex mixture of active compounds. However, it is known to be rapidly absorbed after oral administration, with peak plasma concentrations occurring within 1 to 2 hours. The elimination half-life is variable, and the bioavailability of its active components can be influenced by factors such as preparation method and individual metabolism.

Contra-indications

• Hypersensitivity to echinacea or any of its components
• Autoimmune diseases (e.g., multiple sclerosis, lupus)
• Severe allergies, particularly to plants in the Asteraceae family

Adverse effects

• Allergic reactions including rash, itching, and swelling
• Gastrointestinal upset such as nausea and diarrhea
• Dizziness
• Headache

Interactions

• May interact with immunosuppressants, potentially reducing their effectiveness
• Possible interaction with anticoagulants, increasing the risk of bleeding
• May affect the metabolism of certain medications by influencing cytochrome P450 enzymes

Precautions

• Use with caution in individuals with allergies, especially to plants
• Caution in patients with asthma, as it may exacerbate symptoms
• Consult healthcare professional before use in patients with liver disorders

Pregnancy

Safety during pregnancy has not been established; use with caution and consult a healthcare professional.

Breast-feeding

Limited data available; consult a healthcare professional before use while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral capsules
• Liquid extracts
• Teas

Indications

• General wellness support
• Anti-inflammatory effects
• Antioxidant activity
• Digestive aid
• Support for immune function

Dosage

Children: Paediatric dosing should be determined based on the specific extract and its intended use. Consultation with a healthcare provider is recommended for accurate dosing.

Adults: Dosage varies widely depending on the specific extract and formulation. It is essential to follow the manufacturer's instructions or consult a healthcare professional for appropriate dosing.

Mechanism of action

The mechanism of action of herbal extracts can vary significantly based on their constituents. Commonly, they exert their effects through multiple pathways including modulation of neurotransmitter systems, interference with inflammatory processes, or direct antioxidant activity. Some extracts may activate certain receptors or inhibit enzymes related to disease processes.

Pharmacodynamics

The pharmacodynamics of extracts is complex due to the presence of multiple active compounds which can have synergistic or antagonistic effects. These compounds may influence cellular signaling pathways, alter gene expression, or modulate immune response. The overall pharmacological profile is determined by the specific composition of the extract, its concentration, and the biological target it interacts with.

Pharmacokinetics

The pharmacokinetics of extracts involves absorption, distribution, metabolism, and excretion of the active compounds. Generally, herbal extracts are absorbed in the gastrointestinal tract, with bioavailability influenced by factors such as formulation, the presence of food, and individual metabolic differences. Compounds may undergo hepatic metabolism, and elimination can occur through urine or feces, depending on their chemical nature.

Pregnancy

Consult a healthcare professional before use, as the safety of the extract during pregnancy has not been established.

Breast-feeding

Consult a healthcare professional before use, as the safety of the extract during breastfeeding has not been established.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Digestive disorders
• Respiratory tract infections
• Inflammatory conditions
• Support for immune function

Dosage

Children: Pediatric dosing for goldenseal is not well established and should be guided by a healthcare professional. It is important to consider the child's age, weight, and health condition before administration.

Adults: For adults, the typical dosage of goldenseal extract varies based on the concentration of berberine and specific product formulations. It is recommended to follow product-specific guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The primary active compound in goldenseal, berberine, exerts its effects through multiple mechanisms. It is known to inhibit the growth of certain bacteria and fungi by disrupting their cellular functions. Berberine also modulates various signaling pathways, including the inhibition of pro-inflammatory cytokines, which helps in reducing inflammation. Additionally, it may enhance insulin sensitivity and regulate glucose metabolism.

Pharmacodynamics

Goldenseal exhibits various pharmacodynamic properties primarily due to berberine. It shows antimicrobial activity against a range of pathogens, including bacteria and fungi. The anti-inflammatory effects are mediated through the inhibition of nuclear factor kappa B (NF-κB) activation, leading to reduced expression of inflammatory cytokines. Furthermore, berberine has been shown to influence lipid metabolism and may exert cardioprotective effects.

Pharmacokinetics

The pharmacokinetics of goldenseal, specifically berberine, involves absorption from the gastrointestinal tract, followed by extensive metabolism in the liver. Berberine has a low bioavailability due to rapid first-pass metabolism, but it can accumulate in tissues. The elimination half-life of berberine is relatively short, typically ranging from 2 to 4 hours. It is primarily excreted through the biliary system.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Dizziness

Interactions

• May interact with anticoagulants
• May affect the metabolism of certain drugs due to its influence on cytochrome P450 enzymes

Precautions

• Use with caution in patients with liver disease
• Should be avoided in pregnant women due to potential uterine stimulation
• May cause allergic reactions in sensitive individuals

Pregnancy

Goldenseal is not recommended during pregnancy due to potential risks including uterine contractions.

Breast-feeding

Safety during breastfeeding is not established; caution is advised.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Powdered root
• Capsules
• Liquid extract
• Tincture

Dosage

Children: Refer to specific medication guidelines for dosing adjustments due to grapefruit juice interactions.

Adults: Refer to specific medication guidelines for dosing adjustments due to grapefruit juice interactions.

Mechanism of action

Grapefruit juice contains compounds called furanocoumarins, which inhibit cytochrome P450 3A4 (CYP3A4) enzymes in the liver and intestines. This inhibition can lead to increased plasma concentrations of drugs that are metabolized by CYP3A4, resulting in enhanced pharmacological effects and potential toxicity.

Pharmacodynamics

The pharmacodynamic effects of grape juice are closely related to its antioxidant properties, primarily due to resveratrol and flavonoids. These compounds help in reducing oxidative stress and inflammation. However, the primary clinical concern is the modulation of drug metabolism, particularly affecting drugs with a narrow therapeutic index.

Pharmacokinetics

Grapefruit juice can significantly alter the pharmacokinetics of certain medications by affecting their absorption and metabolism. The inhibition of CYP3A4 can lead to increased bioavailability of drugs that are substrates of this enzyme, resulting in higher plasma concentrations. The effects of grapefruit juice can persist for up to 24 hours post-consumption, complicating timing and dosing of affected medications.

Interactions

• grapefruit juice + abemaciclib: Severe (increases exposure)
• grapefruit juice + aliskiren: Severe (decreases exposure)
• grapefruit juice + amiodarone: Severe (increases exposure)
• grapefruit juice + dronedarone: Severe (increases exposure)
• grapefruit juice + rupatadine: Severe (increases exposure)
• grapefruit juice + piperaquine: Severe (increases concentration)
• grapefruit juice + antipsychotics, second generation: Severe (increases exposure)
• grapefruit juice + lurasidone: Severe (increases exposure)
• grapefruit juice + quetiapine: Severe (increases exposure)
• grapefruit juice + cariprazine: Severe (increases exposure)

Pregnancy

Consult healthcare provider for guidance on use during pregnancy.

Breast-feeding

Consult healthcare provider for guidance on use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Heart failure
• Atrial fibrillation
• Atrial flutter
• Supraventricular tachycardia

Dosage

Children: Pediatric dosing should be determined based on clinical guidelines and individual patient factors. It is essential to consult appropriate pediatric dosing references.

Adults: Dosage should be individualized based on clinical response, renal function, and serum concentration monitoring. Refer to specific guidelines for dosing considerations.

Mechanism of action

The active compounds in purpurea, such as digoxin, exert their effects by inhibiting the Na+/K+ ATPase pump in cardiac myocytes. This inhibition leads to an increase in intracellular sodium concentrations, which in turn promotes calcium influx via the sodium-calcium exchanger. The increased calcium levels enhance contractility of the heart muscle (positive inotropic effect), and also help to regulate heart rate by increasing vagal tone and decreasing conduction through the atrioventricular node.

Pharmacodynamics

Purpurea exhibits positive inotropic effects, increasing the force of myocardial contraction, which is beneficial in conditions like heart failure. It also has a negative chronotropic effect, helping to slow down a rapid heart rate. The therapeutic window for the active compounds is narrow, making monitoring of serum levels essential to avoid toxicity.

Pharmacokinetics

The bioavailability of digoxin, one of the primary active ingredients from purpurea, is approximately 60-80% when taken orally. It is primarily eliminated through renal pathways, with a half-life of approximately 36-48 hours in patients with normal renal function. The distribution volume is extensive due to its binding to tissues, particularly cardiac tissues. Factors such as renal function, age, and body weight can significantly affect the pharmacokinetics of purpurea-derived compounds.

Pregnancy

The safety of purpurea during pregnancy has not been established. It is advised to avoid use unless the potential benefits outweigh the risks.

Breast-feeding

Due to lack of data on the excretion of purpurea in breast milk, caution is recommended when used while breastfeeding.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Indications

• Dietary supplement for heart health
• Source of essential fatty acids
• Antioxidant support
• Promotion of digestive health
• Management of cholesterol levels

Dosage

Children: Refer to specific seed type and formulation for dosing information, as it can vary widely based on type and intended use.

Adults: Refer to specific seed type and formulation for dosing information, as it can vary widely based on type and intended use.

Mechanism of action

The bioactive compounds in seeds, such as polyunsaturated fatty acids, phytosterols, and antioxidants, exert various effects in the body. For example, omega-3 fatty acids found in flaxseeds can influence lipid metabolism and reduce inflammation by modulating the production of eicosanoids. Antioxidants such as tocopherols and phenolic compounds can scavenge free radicals, reducing oxidative stress.

Pharmacodynamics

Seeds have shown potential benefits, including the modulation of lipid profiles, reduction in inflammatory markers, and improvement in glycemic control. The consumption of seeds may lead to decreased low-density lipoprotein (LDL) cholesterol levels and increased high-density lipoprotein (HDL) cholesterol levels, contributing to cardiovascular health. The dietary fiber in seeds can also aid in digestive health and promote satiety.

Pharmacokinetics

The pharmacokinetics of seeds can vary widely depending on the type of seed and the specific compounds being analyzed. Generally, the bioactive components are digested and absorbed in the gastrointestinal tract, with fatty acids being incorporated into chylomicrons and transported via the lymphatic system. Antioxidants are absorbed in the small intestine and may have systemic effects, while fiber can influence gastrointestinal motility and fermentation in the colon.

Pregnancy

Consult a healthcare provider before use, as safety during pregnancy is not well established.

Breast-feeding

Consult a healthcare provider before use, as safety during breastfeeding is not well established.

Storage

Store in a cool, dry place, away from direct sunlight.